Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Determining the optimal COVID-19 policy response using agent-based modelling linked to health and cost modelling: Case study for Victoria, Australia

Tony Blakely, Jason Thompson, Laxman Bablani, View ORCID ProfilePatrick Andersen, Driss Ait Ouakrim, Natalie Carvalho, View ORCID ProfilePatrick Abraham, Marie-Anne Boujaoude, View ORCID ProfileAmeera Katar, Edifofon Akpan, Nick Wilson, Mark Stevenson
doi: https://doi.org/10.1101/2021.01.11.21249630
Tony Blakely
1Population Interventions Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ablakely@unimelb.edu.au
Jason Thompson
2Transport, Health and Urban Design (THUD), Melbourne School of Design, The University of Melbourne, Australia. Address: Masson Rd, Parkville VIC 3010
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laxman Bablani
1Population Interventions Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Andersen
1Population Interventions Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Andersen
Driss Ait Ouakrim
1Population Interventions Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Carvalho
3Health Economics Unit, Centre for Health Policy, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Abraham
3Health Economics Unit, Centre for Health Policy, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Abraham
Marie-Anne Boujaoude
1Population Interventions Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ameera Katar
1Population Interventions Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ameera Katar
Edifofon Akpan
1Population Interventions Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Australia. Address: 207-221 Bouverie St., Parkville, VIC 3010, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nick Wilson
4Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme (BODE3), Department of Public Health, University of Otago, Wellington, New Zealand. Address: University of Otago, Wellington, PO Box 7343, Wellington South 6242, New Zealand
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Stevenson
2Transport, Health and Urban Design (THUD), Melbourne School of Design, The University of Melbourne, Australia. Address: Masson Rd, Parkville VIC 3010
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Determining the best policy on social restrictions and lockdowns for the COVID-19 pandemic is challenging.

Objective To determine the optimal policy response ranging from aggressive and moderate elimination, tight suppression (aiming for 1 to 5 cases per million per day) and loose suppression (5 to 25 cases per million per day).

Design Two simulation models in series: an agent-based model to estimate daily SARS-CoV-2 infection rates and time in four stages of social restrictions; a proportional multistate lifetable model to estimate long-run health impacts (health adjusted life years (HALYs) arising from SARS-CoV-2) and costs (health systems, and health system plus GDP).

The net monetary benefit (NMB) of each policy option at varying willingness to pay (WTP) per HALY was calculated: NMB = HALYs × WTP – cost. The optimal policy response was that with the highest NMB.

Setting and participants The State of Victoria, Australia, using simulation modeling of all residents.

Main Outcome and Measures SARS-CoV-2 infection rates, time under various stages of restrictions, HALYs, health expenditure and GDP losses.

Results Aggressive elimination resulted in the highest percentage of days with the lowest level of restrictions (median 31.7%, 90% simulation interval 6.6% to 64.4%). However, days in hard lockdown were similar across all four strategies (medians 27.5% to 36.1%).

HALY losses (compared to a no-COVID-19 scenario) were similar for aggressive elimination (286, 219 to 389) and moderate elimination (314, 228 to 413), and nearly eight and 40-times higher for tight and loose suppression. The median GDP loss was least for moderate elimination ($US41.7 billion, $29.0 to $63.6 billion), but there was substantial overlap in simulation intervals between the four strategies.

From a health system perspective aggressive elimination was optimal in 64% of simulations above a willingness to pay of $15,000 per HALY, followed by moderate elimination in 35% of simulations.

Moderate elimination was optimal from a partial societal perspective in half the simulations followed by aggressive elimination in a quarter.

Shortening the pandemic duration to 6 months saw loose suppression become preferable under a partial societal perspective.

Conclusions and Relevance Elimination strategies were preferable over a 1-year pandemic duration.

Funding Anonymous philanthropic donation to the University of Melbourne.

Question To determine the optimal of four policy responses to COVID-19 in the State of Victoria, Australia (aggressive and moderate elimination, tight suppression (aiming for 1 to 5 cases per million per day) and loose suppression (5 to 25 cases per million per day), based on estimated future health loss and costs from both a health system and partial societal perspective.

Findings From a health system perspective aggressive elimination was optimal in 64% of simulations above a willingness to pay of $15,000 per HALY, followed by moderate elimination in 35% of simulations. Moderate elimination was optimal from a partial societal perspective (i.e., including GDP losses) in half the simulations followed by aggressive elimination in a quarter.

Meaning Whilst there is considerable uncertainty in outcomes for all the four policy options, the two elimination options are usually optimal from both a health system and a partial societal (health expenditure plus GDP cost) perspective.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Anonymous philanthropic donation to the University of Melbourne.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We confirm that we have followed all appropriate research reporting guidelines.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The Victorian Department of Health and Human Services provided Victorian SARS-CoV-2 notification data for calculation of hospitalisation, ICU admission and fatality rates.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Determining the optimal COVID-19 policy response using agent-based modelling linked to health and cost modelling: Case study for Victoria, Australia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Determining the optimal COVID-19 policy response using agent-based modelling linked to health and cost modelling: Case study for Victoria, Australia
Tony Blakely, Jason Thompson, Laxman Bablani, Patrick Andersen, Driss Ait Ouakrim, Natalie Carvalho, Patrick Abraham, Marie-Anne Boujaoude, Ameera Katar, Edifofon Akpan, Nick Wilson, Mark Stevenson
medRxiv 2021.01.11.21249630; doi: https://doi.org/10.1101/2021.01.11.21249630
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Determining the optimal COVID-19 policy response using agent-based modelling linked to health and cost modelling: Case study for Victoria, Australia
Tony Blakely, Jason Thompson, Laxman Bablani, Patrick Andersen, Driss Ait Ouakrim, Natalie Carvalho, Patrick Abraham, Marie-Anne Boujaoude, Ameera Katar, Edifofon Akpan, Nick Wilson, Mark Stevenson
medRxiv 2021.01.11.21249630; doi: https://doi.org/10.1101/2021.01.11.21249630

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1746)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (651)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2930)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (741)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12495)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (319)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2626)
  • Public and Global Health (5336)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)